Clear Cell Sarcoma of the Kidney (CCSK)

A rare pediatric renal malignancy characterized by clear cytoplasm, distinct pathology, potential for late relapse, and propensity to metastasize to bone and lung; requires multimodal treatment and long follow-up.

Overview

Clear cell sarcoma of the kidney (CCSK) is an uncommon malignant tumor that arises in the kidney, most often in young children. It is distinct from the more common Wilms tumor and is notable for its clear-appearing tumor cells under the microscope. CCSK can be aggressive and may spread beyond the kidney, so accurate diagnosis and prompt, multidisciplinary care are important.

Clinical features

Children with CCSK typically present with an abdominal mass, pain, or swelling. Other findings may include fever, blood in the urine, or nonspecific systemic symptoms. CCSK has a greater tendency than some other pediatric renal tumors to metastasize to distant sites; common targets include the bone and the lung.

Pathology and genetics

Microscopically CCSK shows tumor cells with clear or pale cytoplasm and a characteristic growth pattern that distinguishes it from other kidney tumors. In recent years, molecular studies have identified recurrent genetic changes in many cases, helping to refine diagnosis. Immunohistochemistry and genetic testing complement conventional microscopy when the distinction from other pediatric renal neoplasms is uncertain.

Diagnosis and treatment

Diagnosis is based on imaging to define the renal mass and on surgical sampling or removal for histopathologic confirmation. Management typically involves a combination of radical nephrectomy and systemic therapy; chemotherapy and, in selected cases, radiation therapy are used to address microscopic disease and reduce risk of spread. Treatment is planned by pediatric oncology teams experienced with rare renal tumors.

Prognosis and follow-up

Prognosis depends on stage at diagnosis and response to therapy. CCSK is associated with a risk of late relapse, so long-term surveillance is recommended. Follow-up care focuses on monitoring for local recurrence and distant metastases and managing late effects of treatment.

Distinctions and notable facts

CCSK is distinct from Wilms tumor clinically, pathologically, and genetically.
It is rare but important to recognize because of its metastatic potential and need for specific therapy.
Advances in molecular pathology have improved diagnostic accuracy and understanding of tumor biology.